These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Evaluation of body composition during low-dose estrogen oral contraceptives treatment. Franchini M; Caruso C; Nigrelli S; Poggiali C Acta Eur Fertil; 1995; 26(2):69-73. PubMed ID: 9098463 [TBL] [Abstract][Full Text] [Related]
11. [Oral contraception: disadvantages of estrogen reduction]. Denis C Contracept Fertil Sex (Paris); 1993 Jun; 21(6):481-8. PubMed ID: 12318238 [TBL] [Abstract][Full Text] [Related]
12. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Marsman D Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194 [TBL] [Abstract][Full Text] [Related]
13. Continuous oral contraceptives: are bleeding patterns dependent on the hormones given? Edelman AB; Koontz SL; Nichols MD; Jensen JT Obstet Gynecol; 2006 Mar; 107(3):657-65. PubMed ID: 16507938 [TBL] [Abstract][Full Text] [Related]
14. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty. Paterson WF; McNeill E; Young D; Donaldson MD Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967 [TBL] [Abstract][Full Text] [Related]
16. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive. Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781 [TBL] [Abstract][Full Text] [Related]